SV40 large T antigen has been reported to be modified with several different sugars including N-acetylglucosamine, galactose, and mannose. In this report we have reexamined the glycosylation of T antigen and found that while we could detect modification with N-acetylglucosamine, we could not detect any other sugars on the protein. Surprisingly, even though [ 3 H]galactose could be metabolically incorporated into the protein, analysis showed that all of the radioactivity in T antigen had been converted to other species. The N-acetylglucosamine was demonstrated to be linked to the protein in the form of O-linked N-acetylglucosamine, the best characterized form of nuclear and cytoplasmic glycosylation in mammalian systems. We have localized the major site of glycosylation to the amino terminal portion of the molecule. Analysis of mutated T antigen where serines 111/112 were substituted with alanine suggest that these residues constitute a glycosylation site on the protein. These two serines fall within a typical O-linked N-acetylglucosamine glycosylation site (PSS) and are also known to be phosphorylated. Thus, it is likely that competition between phosphorylation and glycosylation occurs at this site.
Introduction
SV40 large T antigen is a polypeptide with a molecular weight of approximately 90,000 that plays an essential role in infection of host cells by SV40 (for a review on T antigen, see Fanning and Knippers, 1992) . It is required for regulation of viral gene expression and viral DNA replication in permissive cells. In nonpermissive cells, T antigen is capable of causing the initiation and maintenance of the transformed phenotype. T antigen has numerous biological activities, including DNA binding, ATP hydrolysis, DNA unwinding, and binding and inactivation of the tumor suppressor proteins p53 and the retinoblastoma gene product. The oncogenic properties of T antigen, presumably mediated by its ability to bind to and inactivate p53 and the retinoblastoma gene product, have been used to better understand the function of these important proteins. In addition, replication of the SV40 mini-chromosome in vitro, which is totally dependent on the presence of T antigen, has provided a rich model system for understanding basic principles of DNA replication in eukaryotic systems.
T antigen has been shown to undergo a number of posttranslational modifications such as phosphorylation (Tegtmeyer et al., 1977) , acetylation (Paucha et al., 1978) , poly ADPribosylation (Goldman et al., 1981) , adenylation (Bradley et al., 1984) , covalent modification with RNA (Carroll et al., 1988b) , and glycosylation (Schmidt-Ullrich et al., 1979 , 1982 Jarvis and Butel, 1985; Schmitt and Mann, 1987; Jarvis and Butel, 1988) , implying that its activity may be regulated at several different levels. An enormous body of data on the phosphorylation of T antigen exists (Fanning and Knippers, 1992) , although very little is known about the other modifications. The major phosphorylation sites on T antigen occur in two regions on opposite ends of the molecule (Schneider and Fanning, 1988; Fanning and Knippers, 1992) . More than 12 ser/thr phosphorylation sites have been mapped. Although a clear function for each site is not understood, many sites have been mutated and shown to have effects on biological functions. Phosphorylation at many of the sites effects both viral replication and/or the transformation function of T antigen (Schneider and Fanning, 1988; Fanning and Knippers, 1992) . In particular, phosphorylation of Thr-124 by a cell cycle dependent kinase has been shown to be essential for T antigen to initiate viral DNA replication (Schneider and Fanning, 1988; McVey et al., 1989) .
Several laboratories have reported that T antigen is modified with sugars. Schmidt-Ullrich and coworkers (1979, 1982) were the first to suggest that T antigen can be metabolically radiolabeled with [ 3 H]glucosamine. Subsequently, Jarvis and Butel (1985) showed that in addition to glucosamine, T antigen can be radiolabeled with [ 3 H]galactose. They did not observe radiolabeling with [ 3 H]mannose or -fucose. The incorporation of [ 3 H]glucosamine into T antigen was shown to be resistant to tunicamycin, suggesting that N-glycosylation was not involved. Later, they presented data suggesting that [ 3 H]galactose could be released from T antigen by alkali-induced β-elimination suggesting an O-linkage to the protein. Size fractionation of the released sugars suggested the presence of a galactose-containing disaccharide (Jarvis and Butel, 1988) . Both peptide mapping studies and analysis of T antigen truncation mutants suggested that this disaccharide modified numerous locations along the polypeptide backbone (Jarvis and Butel, 1988) . Schmidt and Mann (1987) confirmed that T antigen could be metabolically radiolabeled with [ 3 H]glucosamine and that the radiolabeling was resistant to tunicamycin. In contrast to the findings of Jarvis and Butel, they observed radiolabeling of T antigen with mannose. They also reported that T antigen interacts with several lectins: lentil lectin, specific for core-fucosylated N-glycans; soybean agglutinin, specific for N-acetylgalactosamine and/or galactose; concanavalin A, specific for α-linked mannosides and/or glucosides. Peptide mapping showed that only a single tryptic peptide was modified with [ 3 H]glucosamine. Although modification of nuclear proteins with O-linked N-acetylglucosamine (O-GlcNAc) is now well established Hart, 1997) , the presence of more complex carbohydrate modifications (e.g., containing galactose, mannose, fucose) on nuclear proteins cannot be explained by our current understanding of glycoprotein biosynthesis. Because of the potential biological importance of such modifications, we have sought to reexamine the reported glycosylation of T antigen. Although the previous reports suggest the presence of sugars on T antigen, no agreement on the composition or the structure of the sugar modification was obtained. Thus, it is not clear exactly which sugars are present on T antigen or how they are linked to the protein. For these reasons, we have sought to clarify the composition and structure of the proposed sugar modification(s) on T antigen. We have found that T antigen is modified with glucosamine in the form of O-GlcNAc, the best described form of nuclear and cytoplasmic glycosylation to date Hart, 1997 ). We have not been able to show that T antigen is modified with any other sugars, either as mono-or oligosaccharides. In addition, we have mapped a site of glycosylation to a known phosphorylation site in the amino-terminal region of the molecule. These results add support to the contention that complex carbohydrate (e.g., "classical" N-linked or mucin-type O-linked glycosylation) modifications of proteins do not exist in the nuclear and cytoplasmic compartments of the cell.
Results

T antigen is modified with glucosamine
Our initial studies were designed to reproduce some of the previously reported observations suggesting that T antigen is glycosylated (Schmidt-Ullrich et al., 1979 , 1982 Butel, 1985, 1988; Schmitt and Mann, 1987) . We sought to reproduce these findings by metabolic radiolabeling of T antigen with radioactive sugars in SV40 infected CV-1 cells followed by immunopurification of the protein. Mock-infected cells were used as a control. Using conditions similar to those described in the previous reports, we obtained strong labeling of T antigen with both [ 3 H]galactose and [ 3 H]glucosamine ( Figure 1A) , the two sugars which have been most often reported to exist on T antigen Butel, 1985, 1988; Schmitt and Mann, 1987; Schmidt-Ullrich et al., 1982) . In these experiments we also observed radiolabeling of an unknown species which coprecipitated with T antigen and migrated near the top of the gel (marked "Unknown" in Figure 1A ) with both [ 3 H]galactose and -glucosamine. A second unknown species labeled with [ 3 H]galactose was occasionally observed (see Figure 1A ). Since some previous workers had suggested the presence of mannose and fucose on the protein, we also tried to radiolabel T antigen with these sugars. We were unable to radiolabel T antigen with either [ 3 H]mannose or [ 3 H]fucose ( Figure 1B) . Several different labeling conditions were tried (variations in serum concentrations; presence or absence of fructose, glucose, and pyruvate in the medium) with essentially the same results (data not shown).
Since monosaccharides may be interconverted into other sugars and amino acids during metabolic labelings, it was essential to demonstrate that the radiolabel remained unchanged before drawing conclusions about incorporation of a sugar. The radiolabel was characterized by gel purifying the proteins and subjecting them to strong acid hydrolysis to release the sugars from the protein as monosaccharides. Both T antigen and the Unknown band at the top of the gel (see Figure 1A) were analyzed. After hydrolysis, the [ 3 H]galactose-labeled samples were deionized by passing sequentially over Dowex 50 and Dowex 1. Both the neutral (unbound) and ionic (bound) species were quantified (Table I) . To demonstrate that the technique works well on [ 3 H]galactose-labeled proteins cut out of gels, [ 3 H]galactose-labeled ovalbumin was subjected to SDS-PAGE was taken through the same procedure. Of the radioactivity from ovalbumin released by the acid hydrolysis, the vast majority appeared in the neutral (unbound) fraction (Table I ). Subsequent analysis of this label showed it to be essentially entirely [ 3 H]galactose (data not shown). Significantly, hydrolysis of the T antigen band from the [ 3 H]galactose-labeling resulted in essentially no neutral radioactivity. In contrast, the Unknown band at the top of the gel contained a significant amount of neutral material. This indicated that the [ 3 H]galactose label in the T antigen band was no longer galactose but had been converted to a charged species such as amino acids. The [ 3 H]glucosaminelabeled samples were analyzed by passing over Dowex 50 columns. Since glucosamine is positively charged, it binds to Dowex 50. As shown in Table I , the majority of the radiolabel from both T antigen and the Unknown protein bound and eluted from the Dowex 50 as expected for glucosamine.
After deionizing these fractions on the Dowex columns, they were analyzed individually by high pH anion exchange chromatography for the presence of the appropriate monosaccharide. The neutral fractions were examined for the [ 3 H]galactose-labeled samples, whereas the bound fractions were examined for the [ 3 H]glucosamine-labeled samples. As can be seen in Figure 2A Unknown species contained predominantly glucosamine with a small amount of galactosamine ( Figure 2C ). This was expected since it is well known that an epimerase capable of interconverting glucosamine and galactosamine exists in the cytosol of most cells (Varki, 1994) . The [ 3 H]glucosamine-labeled T antigen band also contained glucosamine, although no significant amount of galactosamine was observed ( Figure 2D ). Thus, in our hands, T antigen appears to be modified with glucosamine but not with galactose. The [ 3 H]galactose incorporated into T antigen appears to have been interconverted into positively charged species such as amino acids. Preliminary data using amino acid analysis suggests that the galactose has been converted mainly into serine and alanine (K. Grove and R. Haltiwanger, unpublished observation).
Since conversion of radioactive sugars (especially galactose) into charged species was such a problem, we modified the labeling conditions from those originally described in an attempt to reduce this conversion. In particular, we added excess nonessential amino acids to the labeling media. This significantly decreased the amount of radiolabel incorporated into T antigen with [ 3 H]galactose, although significant radiolabeling with [ 3 H]glucosamine still occurred ( Figure 1B ). Acid hydrolysis of the incorporated radiolabel under these conditions was consistent with the results reported above (data not shown). Therefore, all subsequent radiolabelings were performed in the presence of the excess nonessential amino acids.
The glucosamine on T antigen is in the form of O-GlcNAc
Once we knew that T antigen was modified with glucosamine, we wanted to determine how the sugar was linked to the protein.
Most previous reports had suggested that T antigen was not N-glycosylated (Jarvis and Butel, 1985; Schmitt and Mann, 1987) . We confirmed this by demonstrating that [ 3 H]glucosamine linked to T antigen was unaffected by digestion with the enzyme peptide N-glycosidase F (data not shown). Since the best characterized form of nuclear and cytoplasmic glycosylation is O-GlcNAc Hart, 1997) , we next sought to determine whether the [ 3 H]glucosamine on T antigen was in the form of O-GlcNAc. Gel-purified, [ 3 H]glucosamine-labeled T antigen was subjected to alkali-induced β-elimination in the presence of excess sodium borohydride to release O-linked sugars from the protein. The released saccharides were then acid hydrolyzed to break down any oligosaccharides to monosaccharides, and the resulting saccharides were analyzed by high pH anion exchange chromatography. Since the sodium borohydride reduces any free reducing sugar to the corresponding sugar alcohol, we could determine whether the glucosamine was linked directly to the protein (through a serine or threonine) by examining whether it was converted to glucosaminitol. Again, as a control, the [ 3 H]glucosamine-labeled Unknown species at the top of the gel (see Figure 1A ) was also analyzed using this technique. Analysis of the β-eliminated material from T antigen showed that the label was almost entirely in the form of [ 3 H]glucosaminitol ( Figure 3A) , indicating that the glucosamine was in fact O-linked to T antigen. Thus, T antigen appears to be modified by O-GlcNAc. In contrast, the majority of the radiolabel from the Unknown species was in the form of glucosamine ( Figure 3B ), indicating that the glucosamine on this protein was linked through other sugars and not directly to the protein. A significant amount of galactosaminitol was also detected, demonstrating that the Unknown species contains mucin-type O-linked structures. Table I ) were analyzed by high pH anion exchange chromatography as described in Jarvis and Butel had suggested that T antigen was modified with a galactose-containing, O-linked disaccharide (1988) . To determine whether the O-GlcNAc on T antigen was elongated in any way, we performed size fractionation of the radiolabel [ 3 H]Glucosamine-labeled T antigen (A) and Unknown (B) were gel purified and subjected to alkali-induced β-elimination followed by acid hydrolysis as described in Materials and methods. The released saccharides were then analyzed by high pH anion exchange chromatography as described in Materials and methods. The elution position of the following standards is shown: 1, galactosaminitol; 2, glucosaminitol; 3, galactosamine; 4, glucosamine.
released by β-elimination on a calibrated BioGel P4 column. The majority of the released radiolabel migrated at the expected size of an N-acetylhexosaminitol monosaccharide (Figure 4) , which migrates at the position of approximately 2.5 glucose units on a BioGel P4 column (Kobata, 1994) . Thus, we found no evidence for a disaccharide or any other significant elongation of the O-GlcNAc on T antigen.
A major site of glycosylation lies in the N-terminal region of T antigen
In order to begin localizing the O-GlcNAc modification on T antigen, we took advantage of previous studies which have mapped the migration position of partial tryptic peptides from T antigen on SDS-PAGE (Schwyzer et al., 1980) . In these studies, Fig. 4 . O-GlcNAc on T antigen is not elongated. [ 3 H]Glucosamine-labeled T antigen was purified by SDS-PAGE and subjected to alkali-induced β-elimination as described in Materials and methods. The products were separated by gel filtration chromatography on BioGel P-4. The migration position of glucose polymers generated from hydrolyzed dextran are shown (diamonds). The migration position of authentic N-acetylglucosaminitol is indicated by the arrow.
the partial trypsin fragments were isolated and identified by N-terminal sequencing (see Figure 7 for a map of the results). Interestingly, Arg-130 was shown to be a hypersensitive trypsin site (see Figure 7) . The majority of the fragments had this cleavage site in common (e.g., 40, 42, 58, 67, and 71 kDa fragments). We have reproduced this technique using [ 35 S]methionine-labeled T antigen and generated the expected fragments ( Figure 5A ). We have also analyzed [ 3 H]glucosamine-labeled T antigen by the same technique ( Figure 5B ). The major [ 3 H]glucosamine-labeled species comigrated with the 17 kDa fragment derived from the N-terminal 130 amino acids. Fainter species were observed at 40, 42, and 58 kDa. These fragments overlap and are derived from the central region of the molecule (see Figure 7) , suggesting the presence of a second site of glycosylation. None of these fragments were obtained from a mock-infected sample, demonstrating that they are derived from T antigen (data not shown). Thus, there appear to be at least two sites of O-GlcNAc modification on T antigen, and one of the sites occurs within the N-terminal 130 amino acids.
Serines 111 and 112 appear to be a site of glycosylation on T antigen
Once we knew that a site of glycosylation was present in the 17 kDa amino terminal region (amino acids 1-130), we began to evaluate individual Ser/Thr residues for modification. The first 82 amino acids of large T antigen have an identical sequence to small t antigen with Ser/Thr in only four positions (Ser-10, Ser-22, Thr-57, Thr-81). The antibody we use for immunoprecipitations of large T antigen (PAb 419) also precipitates small t antigen, and small t antigen migrates at approximately 20,000 Da on SDS-PAGE. Although only small amounts of small t antigen are detected at the stage of infection used in our studies, we have never observed [ 3 H]glucosamine labeling of small t, even after extended exposure of fluorographs (data not shown). Previous workers did not detect radiolabeling of small t antigen with sugars either (Jarvis and Butel, 1985; Schmitt and Mann, 1987) . Thus, the site of glycosylation in the 17 kDa fragment is likely to occur between amino acids 83 and 130. Within this region, two serines (111 and 112) fall into a typical Class I O-GlcNAc site ) (see Figure 7) , suggesting that these residues are good candidates for the site of glycosylation. To evaluate whether these amino acids were in fact glycosylated, we obtained plasmids containing T antigen with alanine substitutions at either these two or several other serines (Schneider and Fanning, 1988) . CV-1 cells were transfected with plasmids bearing wild type and mutant T antigen and labeled with [ 3 H]glucosamine. Immunoblot analysis of extracts from transfected cells was used to follow the level of T antigen protein expressed (Figure 6 ). Both SV106 (Ala to Ser substitution at Ser-106) and wild type T antigen were expressed at comparable levels, whereas SV111/112 (Ala to Ser substitutions at both Ser-111 and Ser-112) was produced at a somewhat lower level (∼60% of the level of SV106 based on densitometric scans). This is consistent with what had been observed with these two mutants previously (Schneider and Fanning, 1988) . Control cells (-DNA) did not produce any T antigen. Analysis of the [ 3 H]glucosaminelabeled samples demonstrated that the T antigen with SV111/112 mutant labeled significantly less than either wild type or the SV106 mutant (Figure 6 ). A contaminating protein species present in all of the samples also labeled with [ 3 H]glucosamine (labeled "Unk" in Figure 6 ), but this unknown protein was not T antigen since it appeared even in the -DNA control sample. This contaminant did not appear in [ 3 H]glucosamine-labeled samples from uninfected cells during our earlier labeling studies (see (Schwyzer et al., 1980) are shown. In addition, the sequence of the carboxy-terminal portion of the 17 kDa fragment is shown. The arrows indicate known sites of phosphorylation (Fanning and Knippers, 1992) . The underlined portion shows the predicted Class I O-GlcNAc glycosylation site .
"Mock" lane, Figure 1A ) and may result from the transfection procedure itself. Several other alanine mutants were also examined (Ser-676, -679, and Thr-701) which showed no significant change in glycosylation state (data not shown). These results suggest that serines 111 and 112 are a major site of glycosylation on T antigen.
Discussion
In this study we have shown that T antigen is modified with O-GlcNAc, the most common form of glycosylation found in the nuclear and cytoplasmic compartments of the cell Hart, 1997) . Although several laboratories had reported modification of T antigen with other carbohydrates including mannose and galactose (Schmidt-Ullrich et al., 1979 , 1982 Jarvis and Butel, 1985; Schmitt and Mann, 1987; Jarvis and Butel, 1988) , we found no evidence for modification of T antigen with any sugars other than glucosamine. We also saw no evidence for elongation or modification of the O-GlcNAc moiety. Finally, we have localized what appears to be a major site of glycosylation to the N-terminal region of T antigen. Substitution of serines 111 and 112 with alanine caused a significant reduction in the amount of [ 3 H]glucosamine to be incorporated into T antigen, indicating that one or both of these serines are the most likely glycosylation sites in the N-terminal region.
Significantly, all previous reports on the glycosylation of T antigen have suggested that T antigen is modified with glucosamine (Schmidt-Ullrich et al., 1979 , 1982 Butel, 1985, 1988; Schmitt and Mann, 1987) . In contrast, there has been disagreement on the presence of other sugars. For instance, Schmidt and Mann (1987) reported modification of T antigen with mannose, galactose, and possibly fucose. Neither in the initial report by Jarvis and Butel (1985) nor in this study was any evidence for mannose or fucose on T antigen obtained. Jarvis and Butel (1985) reported the presence of galactose on T antigen, and this was supported by lectin binding data from Schmidt and Mann (1987) . Although we did see significant radiolabeling of T antigen with [ 3 H]galactose, all of the radioactivity appears to have been converted into other species. Unlike [2-3 H]mannose, which loses its label when it isomerizes to fructose and enters the glycolytic pathway (Varki, 1994) , the label on [6-3 H]galactose is retained when the compound is interconverted into other species. Nonetheless, Jarvis and Butel (1985) presented evidence suggesting that in their system interconversion had not occurred. We cannot explain these differences. Both studies were performed with wild-type SV40 in green monkey kidney fibroblasts, and we reproduced their labeling procedures as faithfully as possible. It is possible that there may be slight differences between the CV-1 cells we used and the TC-7 cells (clonally derived from CV-1 cells) used by Jarvis and Butel. Jarvis and Butel (1988) also reported that the [ 3 H]galactose was found on a O-linked disaccharide modifying T antigen. As they suggested, the simplest explanation for this would be elongation of O-GlcNAc. Although we did find evidence for the O-GlcNAc modification, we found no evidence suggesting the presence of an O-GlcNAc containing disaccharide. Thus, in our hands, T antigen appears to be modified solely with the monosaccharide O-GlcNAc. These results add further support to the contention that classical-type N-and/or O-linked oligosaccharides do not exist on nuclear proteins (Medina and Haltiwanger, 1998) .
Interestingly, Jackson and Tjian (1988) were unable to label T antigen with galactosyltransferase and UDP-[ 3 H]galactose, the standard method for detection of O-GlcNAc. We have had mixed results with galactosyltransferase labeling of T antigen. Denaturing of the protein prior to labeling appeared to help some, but the labeling was weak and inconsistent. The best results were obtained by digesting the protein with trypsin prior to galactosyltransferase labeling. Even under these conditions, insufficient label could be incorporated to successfully purify the O-GlcNAc modified peptides for identification. These results suggested that the stoichiometry of O-GlcNAc modification is extremely low. Based on the amount of [ 3 H]galactose incorporated into galactosyltransferase-labeled tryptic peptides from T antigen, we have estimated that less than 10% of T antigen molecules are modified with O-GlcNAc.
The partial tryptic mapping of glycosylated T antigen suggested the presence of two glycosylation sites: one in the N-terminus (amino acids 1-130) and one in the central domain.
The presence of two glycosylation sites on T antigen was supported by the observation of two labeled peaks during reverse-phase HPLC analysis of galactosyltransferase-labeled T antigen tryptic peptides (L. Medina and R. Haltiwanger, unpublished observation) . Based on the partial tryptic mapping studies, the major site appears to be present in the N-terminal 130 amino acids. The fact that the alanine substitutions at serines 111 and 112 resulted in a significant decrease in [ 3 H]glucosamine labeling strongly suggests that these serines are glycosylated. This conclusion is supported by the fact that these two serines follow a proline, which is a common motif in O-GlcNAc modification sites (Class I site; . The fact that elimination of serines 111 and 112 resulted in such a dramatic decrease in glycosylation suggests that this is the major glycosylation site on T antigen. Alternatively, these mutations could have indirect effects on glycosylation at other sites through conformational changes. We have not yet been able to locate the second glycosylation site within the 40 kDa fragment. There are no proline-containing sites in the central domain which are reminiscent of classic O-GlcNAc glycosylation sites, making assignment of candidate sites in this region difficult.
Some data is available on the role serines 111 and 112 play in the function of T antigen. Alanine substitutions at these positions result in a significant reduction in the replication efficiency of SV40 (44% of wild type based on plaque assay), suggesting a role in viral replication (Schneider and Fanning, 1988) . In addition, residues 111 and 112 fall within the region of T antigen known to be responsible for binding to the retinoblastoma gene product (amino acids 105-115) (Fanning and Knippers, 1992) , suggesting that modification with O-GlcNAc could play a role in modulating this interaction. Serines 111 and 112 are also known phosphorylation sites (Fanning and Knippers, 1992) , and serine 112 has been shown to be phosphorylated in vitro by casein kinase II (Carroll et al., 1988a; Grasser et al., 1988) . Thus, it is likely that competition between O-GlcNAc and phosphate for this site exists in vivo. Similar competition has been proposed to exist on myc and RNA polymerase II, both of which have glycosylation and phosphorylation sites mapped to identical residues (Kelly et al., 1993; Chou et al., 1995) . These results support the hypothesis that competition between O-GlcNAc and phosphate does occur in vivo and may serve as an independent means of altering phosphate levels on selected proteins. Such competition may also explain the low stoichiometry of O-GlcNAc we see on T antigen.
Materials and methods
Materials
Wild type SV40 and the monoclonal antibody PAb 419 were generously provided by Dr. Peter Tegtmeyer (Department of Microbiology, SUNY-Stony Brook). Plasmids bearing wild type and mutated T antigen were generously provided by Dr. Ellen Fanning (Department of Molecular Biology, Vanderbilt University). CV-1 cells were obtained from the Tissue Culture Facility, Department of Microbiology, SUNY-Stony Brook. Dulbecco's modified Eagle's medium (DMEM), glucose-free DMEM, methionine-free DMEM, Eagle's minimal essential medium (MEM), methionine-free MEM, the components to make glucose-free MEM, and fetal bovine serum were all from Gibco-BRL. Radioactive sugars ([6-3 All electrophoresis reagents, BioGel P4 and Analytical grade Dowex 50×8 (H + form) and Dowex 1×8 (formate form) were from Bio-Rad. Trifluoroacetic acid (HPLC grade) and HCl were from Pierce. All other reagents were of the highest quality available.
Infections and metabolic labelings
Initial infections and metabolic labelings (e.g., for Figure 1A ) were performed essentially as described by Jarvis and Butel (Jarvis and Butel, 1985) . CV-1 cells were maintained in MEM containing 10% fetal bovine serum and penicillin/streptomycin (complete MEM). Metabolic labelings were performed for 3 h in glucose-free MEM 21 h postinfection. In all subsequent experiments, CV-1 cells were maintained in DMEM containing 10% fetal bovine serum and penicillin/streptomycin (complete DMEM). Metabolic labeling with radioactive sugars was performed 21 h postinfection by starving the infected or mock infected cells in glucose-free DMEM containing 10% fetal bovine serum and 2× nonessential amino acids for 30 min. Radiolabeled sugar was then added (100-500 µCi/ml of media), and the cells were labeled for 3 h. [ 35 S]Methionine radiolabeling was performed in an identical fashion except that methionine-free DMEM was substituted for the glucose-free DMEM.
Extraction, immunoprecipitation, and gel electrophoresis
After metabolic labeling, the cells were washed three times with Tris-buffered saline (10 mM Tris-HCl, pH 7.5, 0.15 M NaCl) and lysed in Extraction Buffer (1 ml/100 mm dish, 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1% (w/v) NP-40, containing 1 mM PMSF added just before use). The extracts were clarified by centrifugation (10,000 × g, 10 min, 4 _C), and T antigen was purified by immunoprecipitation using the anti-T antigen monoclonal antibody 419 as described previously (Jarvis and Butel, 1985) . Immune complexes were collected using Pansorbin (Calbiochem) or Protein A-Sepharose (Sigma). The radiolabeled T antigen was eluted from the complex by boiling in SDS-PAGE sample buffer, and the samples were separated by 10% SDS-PAGE (Laemmli, 1970) . Gels were stained with Coomassie blue and processed for fluorography with En 3 Hance as described by the manufacturer.
Product characterization
Acid hydrolysis. Metabolically labeled samples were prepared as described above. Radioactive species were identified by SDS-PAGE and fluorography. The appropriate bands were cut out of the gel, cut into small pieces, and placed into an acid-washed, 13 × 100 mm screw cap tube. The gel pieces were rehydrated with 1 ml Milli Q (Millipore) water for 10 min. The water was removed, and the gel pieces were washed three times with 1 ml of Milli Q water. Acid hydrolysis was performed on the washed gel pieces essentially as described previously (Hardy and Townsend, 1994) . [ 3 H]Galactose-labeled samples were hydrolyzed in 0.5 ml of 2 M TFA for 2 h at 100_C. [ 3 H]Glucosaminelabeled samples were hydrolyzed in 0.5 ml of 4 M HCl for 4 h at 100_C. The hydrolysate was removed from the gel pieces and dried in a Speed Vac concentrator (Savant). The samples were resuspended in 1 ml of Milli Q water, and an aliquot of each was counted to determine the total amount of radioactivity released by the acid hydrolysis. The [ 3 H]galactose-labeled samples were then passed over a column of 0.5 ml Dowex 50×8 and 0.5 ml Dowex 1×8. The columns were washed with 5 volumes of water. The flowthrough and wash were collected as one sample termed "unbound." The charged species were then eluted with 5 volumes of 2 M HCl and termed "bound and eluted." The [ 3 H]glucosamine-labeled species were passed over a 0.5 ml Dowex 50×8 column (no Dowex 1) but treated the same otherwise. All fractions were dried in a Speed Vac as above and resuspended in Milli Q water. Aliquots of all fractions were counted to determine yield. Separation of monosaccharides on a Dionex PA-1 column was performed as described (Hardy and Townsend, 1994) . Each sample was injected with internal standards (fucose, galactosamine, glucosamine, galactose, glucose, mannose), which were followed by pulsed amperometric detection (Hardy and Townsend, 1994) . Fractions (0.2 min) were collected and monitored for radioactivity by scintillation counting with Formula 989 (Dupont-NEN). [ 3 H]Galactose-labeled ovalbumin was prepared by labeling ovalbumin with galactosyltransferase and UDP-[ 3 H]galactose as described previously .
Alkali-induced β-elimination.
[ 3 H]Glucosamine-labeled samples were prepared as described above for acid hydrolysis. After excising the appropriate band and washing with Milli Q water, 1 ml of 0.1 M NaOH, 1 M NaBH 4 was added, and the samples were incubated at 37_C for 18-24 h. The reaction was stopped by neutralizing with 4 M acetic acid on ice. The gel pieces were removed, and the neutralized sample was passed over a 3 ml column of Dowex 50×8. The column was washed with 12 ml water, and the flowthrough and wash were lyophilized. The boric acid was removed by repeated evaporation with methanol in a Speed Vac concentrator (medium heat). The samples were hydrolyzed in 2 M TFA for 2 h at 100_C. The acid was removed by repeated evaporation in a Speed Vac concentrator. Amino sugar alcohols (glucosaminitol and galactosaminitol) were separated by HPAEC on a Dionex PA-1 column as described previously (Haltiwanger et al., 1990) . Each sample contained the following standards: galactosaminitol, glucosaminitol, galactosamine, glucosamine. Galactosaminitol and glucosaminitol were generated by acid hydrolysis (2 M TFA, 2 h, 100_C) of the corresponding N-acetylhexosaminitol (obtained from Sigma). Fractions (0.2 min) were collected and analyzed for radioactivity as above. Size analysis of β-eliminated material (no acid hydrolysis) was performed on a calibrated BioGel P4 column (1.5 × 100 cm) in water. Partially hydrolyzed dextran was used as size standards as described previously (Kobata, 1994) .
Peptide mapping of T antigen by partial tryptic digestion
Partial digestion of T antigen was performed essentially as published (Schwyzer et al., 1980) . CV-1 cells were infected with SV40 and labeled with either [ 35 S]methionine or [6-3 H]D-glucosamine as described above. The cells were lysed with extraction buffer (0.1 M Tris-HCl, pH 9.0, containing 0.1 M NaCl, 0.005 M KCl, 0.001 M CaCl 2 , 0.0005 M MgCl 2 and 0.5% (w/v) Nonidet P-40). T antigen was immunoprecipitated as described above using Protein A-agarose. After washing, the immune complexes were resuspended in 0.2 ml of extraction buffer (filter sterilized) containing 5 µg of TPCK-trypsin (Sigma) and incubated for 15 min on ice. The digestion was stopped by addition of 10 µl of 0.5 M phenylmethylsulfonylfluoride. The samples were then analyzed by SDS-PAGE (5 cm 15% acrylamide overlaid with 6.5 cm of 7.5% acrylamide) and fluorography. In the case of methionine labelings, only one third of the sample was loaded onto the gel. For glucosamine-labeled samples the total sample was loaded. Partial peptides were identified by apparent migration on the gel in comparison with molecular weight standards.
Transfection of CV-1 cells with plasmids bearing wild type and mutated T antigen
Plasmids (pSDL) containing the entire coding sequence of SV40 with wild or mutant T antigen were used for the transfection studies (Schneider and Fanning, 1988) . The mutants were serine to alanine substitutions at positions 106 (SV106) and 111/112 (SV111/112) (Schneider and Fanning, 1988) . DNA/liposome complexes were formed by the manufacturer's instructions (1 µg DNA to 5 µl of liposome suspension). Subconfluent CV-1 cells were transfected with 5-15 µg of DNA in serum free DMEM (3 ml/100 mm dish). After 4 h an equal volume of DMEM with 20% fetal calf serum was added and incubated overnight. Fresh DMEM with 10% fetal calf serum was added, and the cells were incubated until signs of lytic infections were present (∼96 h). The transfected cells were then processed for [ 3 H]glucosamine radiolabeling as described above. Identical samples were prepared from unlabeled plates, and the expression levels of T antigen were monitored by immunoblot analysis using the 419 antibody as described previously (Harlow and Lane, 1988) .
